Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
Evofem Biosciences, Inc. (EVFM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 141,000 shares
@ $0.3525, valued at
$49.7k
|
|
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Granted 300,000 shares
@ $0 Granted 300,000 options to buy
@ $0.49, valued at
$147k
|
|
02/23/2022 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Granted 450,000 shares
@ $0 Granted 450,000 options to buy
@ $0.49, valued at
$220.5k
|
|
02/23/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Granted 750,000 shares
@ $0 Granted 750,000 options to buy
@ $0.49, valued at
$367.5k
|
|
01/04/2022 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Disposed/sold 120,000 shares
@ $0 |
|
01/04/2022 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Disposed/sold 120,000 shares
@ $0 |
|
01/04/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Disposed/sold 300,000 shares
@ $0 |
|
12/20/2021 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 25,000 shares
@ $0.389, valued at
$9.7k
|
|
12/20/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 40,594 shares
@ $0.37, valued at
$15k
|
|
12/20/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 135,000 shares
@ $0.375, valued at
$50.6k
|
|
07/09/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Paid exercise price by delivering 19,998 shares
@ $0.975, valued at
$19.5k
|
|
06/21/2021 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 10,000 shares
@ $1.165, valued at
$11.7k
|
|
06/14/2021 |
4
| Rarick Lisa Dale (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 5,000 shares
@ $1.198, valued at
$6k
|
|
06/14/2021 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 8,140 shares
@ $1.31, valued at
$10.7k
|
|
06/11/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 18,180 shares
@ $1.14, valued at
$20.7k
|
|
06/10/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 24,500 shares
@ $1.03, valued at
$25.2k
|
|
06/10/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Bought 50,000 shares
@ $1.03, valued at
$51.5k
|
|
06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Paid exercise price by delivering 31,480 shares
@ $0.86, valued at
$27.1k
|
|
05/21/2021 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Paid exercise price by delivering 42,061 shares
@ $0.86, valued at
$36.2k
|
|
05/21/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Paid exercise price by delivering 42,280 shares
@ $0.86, valued at
$36.4k
|
|
05/21/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Paid exercise price by delivering 105,300 shares
@ $0.86, valued at
$90.6k
|
|
05/13/2021 |
4
| Greer Gillian (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Granted 90,000 options to buy
@ $1.25, valued at
$112.5k
|
|
05/13/2021 |
4
| Rutherford Colin (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Granted 90,000 options to buy
@ $1.25, valued at
$112.5k
|
|
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns:
| Granted 90,000 options to buy
@ $1.25, valued at
$112.5k
|
|
|
|
|